Mpox Vaccines Commitment: Bavarian Nordic to Deliver Two Million Doses for Africa
Thursday, 12 September 2024, 06:53
Mpox Vaccines Commitment
Bavarian Nordic is making significant strides in the fight against mpox by pledging to deliver two million vaccines to Africa by the end of 2024. This boost in supply aims to address the urgent needs voiced by health authorities.
Further Supply Promises
- Bavarian Nordic could also supply 13 million doses by the end of 2025.
- This addition is in direct response to requests from the Africa CDC and UNICEF.
- The company is committed to supporting vaccination campaigns across the continent.
Mpox remains a pertinent public health challenge, and increased vaccine availability is critical to controlling its spread.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.